Loading clinical trials...
Loading clinical trials...
This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Institute on Aging (NIA)
NCT07571161 · Alzheimer Disease
NCT06847321 · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
NCT06937229 · Alzheimer Disease, Agitation
NCT07633470 · Alzheimer Disease
NCT04579120 · Alzheimer Disease
University of Alabama, Birmingham
Birmingham, Alabama
University of Southern California
Los Angeles, California
University of California, San Diego
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions